stockrow
Friday 6 November 2026
Export YI’s income statement to Excel — free account
111, Inc. Sponsored ADR
YI Healthcare Medical Distribution
111, Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 9.00% from fiscal 2024.
- Revenue
- −29.6%
- EPS
- −113.7%
- Free cash flow
- −185.7%
- Total debt
- +82.5%
Quarter to March 2026, against a year earlier
2.90
0.08
−2.68%
Follow YI
Alert me
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 5 | 5 | 4 |
| 11.19% | 10.10% | 9.82% | 12.26% | ||
| (2.80%) | (2.45%) | (2.73%) | (3.89%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(24.98%) | (36.78%) | (34.53%) | (52.06%) | |
Average Days of Receivables |
6.94 | 7.78 | 7.55 | 6.05 | |
Free Cash Flow per Share |
1.78 | 0.48 | 1.01 | (1.34) | |
Free Cash Flow |
15.42 | 4.17 | 8.84 | (11.78) | |
Capital Expenditures |
— | — | (8.20) | — | |
| Other line items | |||||
Cash ROIC |
(1,355.36%) | 127.92% | 79.76% | 77.70% | |
Accounts Receivable Turnover |
41.58 | 37.06 | 38.31 | 51.50 | |
Accounts Payable Turnover |
8.42 | 7.15 | 8.07 | 7.64 | |
Inventory Turnover |
10.03 | 8.88 | 10.17 | 9.37 | |
Average Days of Payables |
43.09 | 45.38 | 39.56 | 41.22 | |
Days of Inventory on Hand |
35.43 | 36.71 | 30.80 | 34.55 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.52% | 2.53% | 2.61% | 2.74% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 3.32% | 0.00% | |
Interest Coverage |
(0.16) | (0.32) | (0.07) | (0.65) | |
Operating CF/Net income |
(1.51) | (0.44) | (1.79) | 0.95 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 4.31 | 0.00 | |
Capex/Depreciation |
— | — | (0.63) | — | |
Revenue per Share |
224.33 | 212.99 | 204.90 | 187.78 | |
Operating CF per Share |
1.78 | 0.48 | 1.94 | (1.34) | |
Capex per Share |
0.00 | 0.00 | (0.94) | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026